Invitrotek

Invitrotek, IVT is a sales & marketing company which is focused on molecular diagnostics , genetic testing and drug of abuse testing market in Turkey. Established in January 2009, IVT aims to be in the process of building a healthier community and future with the help of its stake holders in the Turkish healthcare value chain. The team of the employees brings the company’s core competency into existence with their market expertise and field knowledge. In the light of the fact that having a high quality after sales service is among the important success factors in Turkish IVD market, IVT has a well experienced product support and technical service department and put a training program into place for its sub-dealers. Another important asset for the company is its established distribution network consists of direct sales force and well respected regional dealers. With the help of its well established distribution network, IVT has ability to create high product penetration rates within a short term of marketing.

nice neotech medical systems pvt. ltd.

nice Neotech, NICE stands for Neonatal Intensive Care Equipments provides health care equipments to the hospital needs, Neonatal care equipment, Neonatal Intensive Care Equipments also have all types of baby incubator and Anaesthesia machine.

Venture Medical

Global sourcing, local representation. We’re focused on advancing the standard of care through state-of-the-art diagnostics and treatments. Areas of specialty include Biofilm Management, Wound, Urology, Pulmonology, Burn, Plastics, Vascular, Podiatry and Surgery.

merdas raman business development co.

MRBD® has been established on January 9, 2021, with registration number 571014 in the capital of Iran (Tehran) to operate in the field of international trade. Since the issue of health and public health affects the quality of life directly, the founders of our company turned to the international trade of medical equipment with extensive and careful studies of domestic and foreign markets. To achieve this purpose, we have planned a detailed business plan. So, we can experience successful cooperation with partners inside and outside of Iran and give an easier life for everyone.

Qynapse

The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust. Headquartered in France, in the United States and in Canada, the Qynapse team, with our world-renowned team of scientific and clinical partners, is wholly dedicated to aspiring to bring the entire neuroscience community and their patients the clearest, most accurate and reliable predictors and objective measures of devastating CNS disorders such as Alzheimer's disease, multiple sclerosis and Parkinson’s disease. We are constantly evolving, refining and testing our FDA-cleared and CE-marked neuroimaging software platform, QyScore®, which is powered by proprietary Artificial Intelligence, to provide physicians, pharma researchers and payers a reliable layer of precision when reading an MRI scan. QyPredict®, our predictive research-use-only platform powered by machine learning algorithms, is being designed to transform what we know about CNS disease trajectory, with the potential to dramatically increase the likelihood of a successful clinical trial. Together, we are moving forward to a brighter and more accurate future of diagnosis and treatment for central nervous system diseases.